Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Patterson, R.N.
Right arrow Articles by Herity, N.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patterson, R.N.
Right arrow Articles by Herity, N.A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2002; 95: 58-59
© 2002 Association of Physicians

Correspondence

Acute myocardial infarction following bupropion (Zyban)

R.N. Patterson and N.A. Herity

Craigavon Area Hospital, Portadown, Northern Ireland

Sir,

Bupropion (Zyban) was licensed by the Medicines Control Agency in the UK in June 2000 as an aid to smoking cessation. Subsequent reports of 18 deaths raised questions about its safety.1 We describe a patient who presented with acute myocardial infarction, whose symptoms of chest . . . [Full Text of this Article]

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NEJMHome page
C. C. Butler, S. Rollnick, M. E. Gatt, S. N. Heyman, and N. Rigotti
Treatment of Tobacco Use and Dependence
N. Engl. J. Med., July 25, 2002; 347(4): 294 - 295.
[Full Text] [PDF]